advertisement
11.13.4 Betablocker and prostaglandin (19)
Showing records 1 to 19
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Konstas AG
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Hasebe Y
Patient preference and adherence 2018; 12: 1567-1577
78811 Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension
Soares RR; Razeghinejad MR
Expert Opinion in Pharmacotherapy 2018; 19: 1731-1738
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Kashiwagi K
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katsanos A; Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Tsumura T
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Athanasopoulos GP; Voudouragkaki IC
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Suzuki Y; Yoshikawa K
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Panagiotou ES
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Suzumura H
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Pagkalidou E
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Maeda T
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Haidich AB; Giannoulis DA
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Takeda R
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Spathi E
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Saito H
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Giannopoulos T
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Araie M
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katz LJ
Expert Opinion in Pharmacotherapy 2018; 0: 1-8